Synonyms of nosological groups.

Voltaren is a non-steroidal anti-inflammatory drug (NSAID). It has a pronounced analgesic, anti-inflammatory and antipyretic effect.

NSAIDs for external use. Diclofenac has a pronounced analgesic, anti-inflammatory and antipyretic effect. By indiscriminately inhibiting COX-1 and COX-2, it disrupts the metabolism of arachidonic acid. Voltaren® Emulgel® is used to eliminate pain syndrome and inflammation in joints, muscles and ligaments of traumatic or rheumatic origin, helping to reduce pain and swelling associated with inflammatory process, increasing joint mobility.

— back pain due to inflammatory and degenerative diseases of the spine (sciatica, osteoarthritis, lumbago, sciatica); - pain in the joints (including the joints of the fingers, knees) with rheumatoid arthritis, osteoarthritis; — muscle pain (due to sprains, strains, bruises, injuries); - inflammation and swelling of soft tissues and joints due to injuries and rheumatic diseases (tenosynovitis, bursitis, lesions of periarticular tissues, wrist syndrome).

The drug is used externally. Adults and children over 12 years old The drug is applied to the skin 2 times a day (every 12 hours: preferably in the morning and evening), lightly rubbing into the skin. The required amount of the drug depends on the size of the painful area. Single dose drug - 2-4 g (which is comparable in volume to the size of a cherry or walnut) - sufficient to treat an area of ​​400-800 cm2. If your hands are not the area where pain is localized, then after applying the drug they must be washed. The duration of treatment depends on the indications and the observed effect. The gel should not be used for more than 14 days if post-traumatic inflammation and rheumatic diseases of soft tissues without a doctor's recommendation. If after 7 days of use the therapeutic effect is not observed or the condition worsens, the patient should consult a doctor. To remove the protective membrane, use the screw cap as a key (the recess with protrusions on the outside of the cap). Align the indentation on the outside of the cap with the shaped protective membrane of the tube and turn. The membrane should separate from the tube.

- hypersensitivity to diclofenac or other components of the drug; - tendency to develop attacks of bronchial asthma, skin rashes or acute rhinitis when using acetylsalicylic acid or other NSAIDs; - violation of integrity skin at the intended place of application; — III trimester of pregnancy; - lactation period ( breastfeeding); — childhood up to 12 years; WITH caution the drug should be prescribed for hepatic porphyria (in the acute phase), erosive and ulcerative lesions of the gastrointestinal tract, severe violations liver and kidney function, chronic heart failure, bronchial asthma, as well as in the first and second trimesters of pregnancy and elderly patients.

Due to the low systemic absorption when applying the gel, overdose is unlikely. Symptoms: In case of accidental ingestion, systemic symptoms may develop. adverse reactions. Treatment overdose due to accidental ingestion: gastric lavage, induction of vomiting, Activated carbon, symptomatic therapy. Dialysis and forced diuresis are not effective due to the high degree of binding of diclofenac to plasma proteins (about 99%).

Voltaren® Emulgel® should be applied only to intact skin, avoiding contact with open wounds. After applying the drug, it is allowed to apply bandage However, airtight occlusive dressings should not be applied. In case of development after application of the drug skin rash its use must be discontinued. The drug should not come into contact with the eyes and mucous membranes. This medicine contains propylene glycol, which may cause mild local irritation in some people. It also contains butylated hydroxytoluene, which may cause local skin reactions (eg contact dermatitis) or irritation of the eyes and mucous membranes. Impact on the ability to drive vehicles and operate machinery Does not affect.

Voltaren® Emulgel® may enhance the effect of drugs that cause photosensitivity. Clinically significant interactions with others medicines not described.

The drug should be stored out of the reach of children at a temperature not exceeding 30°C. Shelf life - 3 years.

Tube 150 g

Use during pregnancy and breastfeeding
Due to the lack of data on the use of the drug Voltaren® Emulgel® during pregnancy, the use of the drug in the first and second trimesters of pregnancy is recommended only as prescribed by a doctor, weighing the benefits for the mother and the risk for the fetus.
The drug is contraindicated in the third trimester of pregnancy due to the possibility of decreased uterine tone and/or premature closure ductus arteriosus fetus
Due to the lack of data on the allocation active substance drug Voltaren® Emulgel® with breast milk, the drug is not recommended for use during breastfeeding. If it is still necessary to use the drug, it should not be applied to the mammary glands or large surface areas of the skin and should not be used for a long time.

Overdose

Due to the low systemic absorption when applying the gel, overdose is unlikely.
Symptoms: accidental ingestion may cause systemic adverse reactions.
Treatment of overdose due to accidental ingestion: gastric lavage, induction of vomiting, activated charcoal, symptomatic therapy. Dialysis and forced diuresis are not effective due to the high degree of binding of diclofenac to plasma proteins (about 99%).

special instructions

Voltaren® Emulgel® should be applied only to intact skin, avoiding contact with open wounds.
After applying the drug, a bandage may be applied, but airtight occlusive dressings should not be applied. If a skin rash develops after application of the drug, its use should be discontinued.
The drug should not come into contact with the eyes and mucous membranes.
This medicine contains propylene glycol, which may cause mild local irritation in some people. It also contains butylated hydroxytoluene, which may cause local skin reactions (eg contact dermatitis) or irritation of the eyes and mucous membranes.
Impact on the ability to drive vehicles and operate machinery
Does not affect.

Voltaren Emulgel - intended for pain in the joints, back, muscles, as well as inflammation and swelling of soft tissues and joints. Voltaren Emulgel has a triple effect! 1: against pain 2: against inflammation * 3: to speed up recovery ** The active substance diclofenac is a non-steroidal anti-inflammatory drug with pronounced analgesic and anti-inflammatory properties, penetrates deep into the skin, acting on both pain and its cause - inflammation. * * Instructions for medical use, RU No P N016030/01 dated 09.09.2009 ** Limit. Musculoskeletal disorders. 2013, 14:250. Compared to using placebo.

Active ingredients

Release form

Compound

Per 100 g: Active substance: diclofenac diethylamine 1.16 g, which corresponds to the content of diclofenac sodium 1 g. Excipients: carbomers (carbopol 974P) - 1.2 g, macrogol cetostearate (cetomacrogol 1000) - 2 g, cocoyl caprylocaprate (cetiol LC) - 2.5 g, diethylamine - 0.9 g, isopropanol - 20 g, liquid paraffin - 2.5 g, aromatic cream 45 (contains benzyl benzoate) - 0.1 g, propylene glycol - 5 g, water - 64.64 g.

Pharmacological effect

NSAIDs for external use. Diclofenac has a pronounced analgesic, anti-inflammatory and antipyretic effect. By indiscriminately inhibiting COX-1 and COX-2, it disrupts the metabolism of arachidonic acid. Voltaren® Emulgel® is used to eliminate pain and inflammation in joints, muscles and ligaments of traumatic or rheumatic origin, helping to reduce pain and swelling associated with the inflammatory process, increasing joint mobility. Thanks to its hydroalcoholic base, Voltaren® Emulgel® has a calming and cooling effect.

Pharmacokinetics

Absorption The amount of diclofenac absorbed through the skin is proportional to the area of ​​the treated surface and depends both on the total dose of the drug applied and on the degree of skin hydration. After applying Voltaren® Emulgel®, gel for external use 2% (2 applications per day) to a skin surface area of ​​400 cm2, the concentration of the active substance in plasma corresponds to its concentration when using 1% diclofenac gel (4 applications per day). On day 7, the relative bioavailability of the drug (AUC ratio) is 4.5% (for an equivalent dose sodium salt diclofenac). When wearing a moisture-permeable dressing, suction did not change. Distribution When applying the drug to the area of ​​the affected joint, the concentration of diclofenac in plasma was determined, synovium and synovial fluid. Cmax in plasma was approximately 100 times lower than after oral administration of the same amount of diclofenac. The binding of diclofenac to plasma proteins is 99.7%, mainly with albumin (99.4%). Diclofenac is preferentially distributed and retained deep in tissues prone to inflammation, such as joints, where its concentration is 20 times higher than in plasma. Metabolism The metabolism of diclofenac is carried out partly by glucuronidation of the unchanged molecule, but mainly through single and multiple hydroxylation, which leads to the formation of several phenolic metabolites, most of which are converted to glucuronide conjugates. Two phenolic metabolites are biologically active, but to a much lesser extent than diclofenac. Elimination The total systemic plasma clearance of diclofenac is 263±56 ml/min. The final T1/2 is 1-2 hours. T1/2 of metabolites, including two pharmacologically active ones, is also short-lived and is 1-3 hours. One of the metabolites (3"-hydroxy-4"-methoxydiclofenac) has a longer T1/2, however, this metabolite is completely inactive. Most of diclofenac and its metabolites are excreted in the urine.

Indications

Back pain due to inflammatory and degenerative diseases of the spine (sciatica, osteoarthritis, lumbago, sciatica), joint pain (including finger joints, knee joints) due to rheumatoid arthritis, osteoarthritis, muscle pain (due to sprains, strains, bruises) , injuries), inflammation and swelling of soft tissues and joints due to injuries and rheumatic diseases (tenosynovitis, bursitis, lesions of periarticular tissues, wrist syndrome).

Contraindications

Increased sensitivity to diclofenac or other components of the drug, a tendency to cause attacks of bronchial asthma, skin rashes or acute rhinitis when using acetylsalicylic acid or other NSAIDs, violation of the integrity of the skin at the intended site of application, third trimester of pregnancy, lactation period (breastfeeding), children up to 12 years old.

Precautionary measures

The drug should be prescribed with caution for hepatic porphyria (in the acute phase), erosive and ulcerative lesions of the gastrointestinal tract, severe liver and kidney dysfunction, chronic heart failure, bronchial asthma, as well as in the first and second trimesters of pregnancy and elderly patients.

Use during pregnancy and breastfeeding

Due to the lack of data on the use of the drug Voltaren® Emulgel® during pregnancy, the use of the drug in the first and second trimesters of pregnancy is recommended only as prescribed by a doctor, weighing the benefits for the mother and the risk for the fetus. The drug is contraindicated in the third trimester of pregnancy due to the possibility of decreased uterine tone, impaired fetal renal function with subsequent development of oligohydramnios and/or premature closure of the fetal ductus arteriosus. Due to the lack of data on the release of the active substance of Voltaren® Emulgel® into breast milk, the drug is not recommended for use during breastfeeding. If it is still necessary to use the drug, it should not be applied to the mammary glands or large surface areas of the skin and should not be used for a long time. There are no data on the effect of the drug on fertility.

Directions for use and doses

The drug is used externally. For adults and children over 12 years of age, the drug is applied to the skin 3-4 times a day and lightly rubbed. The required amount of the drug depends on the size of the painful area. A single dose of the drug is 2-4 g (which is comparable in volume to the size of a cherry or walnut, respectively). After applying the drug, hands must be washed. The duration of treatment depends on the indications and the observed effect (to enhance the effect, the gel can be used together with other dosage forms drug Voltaren®). With absence therapeutic effect after 2 weeks you should consult your doctor. Laminated tubes: To remove the protective membrane, use the screw cap as a key (the ridged recess on the outside of the cap). Align the recess on the outside of the lid with the shaped protective membrane of the tube and turn. The membrane should separate from the tube. Laminated tubes can have either a regular cap (round shape) or an innovative cap ( triangular shape), which is especially convenient for use with limited mobility of the joints of the hands due to osteoarthritis or other joint diseases or injuries, as well as an applicator cap. Aluminum tubes: Before first use, the protective membrane of the tube must be pierced using the special protrusion on the outside of the polypropylene screw cap. It is not recommended to rinse the applicator cap with water or use abrasive cleaners. After completely using the contents of the tube, it is recommended to dispose of the applicator cap along with the tube. Do not use the applicator cap with another tube.

Side effects

Overdose

Due to the low systemic absorption when applying the gel, overdose is unlikely. Symptoms: accidental ingestion may cause systemic adverse reactions. Treatment of overdose due to accidental ingestion: gastric lavage, induction of vomiting, activated charcoal, symptomatic therapy. Dialysis and forced diuresis are not effective due to the high degree of binding of diclofenac to plasma proteins (about 99%).

Interaction with other drugs

Voltaren® Emulgel® may enhance the effect of drugs that cause photosensitivity. Clinically significant interactions with other drugs have not been described.

special instructions

Voltaren® Emulgel® should be applied only to intact skin, avoiding contact with open wounds. After applying the drug, a bandage may be applied, but airtight occlusive dressings should not be applied. If a skin rash develops after application of the drug, its use should be discontinued. The drug should not come into contact with the eyes and mucous membranes. This medicine contains propylene glycol, which may cause mild local irritation in some people. It also contains butylated hydroxytoluene, which may cause local skin reactions (eg contact dermatitis) or irritation of the eyes and mucous membranes. Influence on the ability to drive vehicles and operate machinery. No effect.

Storage conditions

The drug should be stored out of the reach of children at a temperature not exceeding 30°C.

Instructions for use

Voltaren Emulgel instructions for use

Dosage form

Homogeneous, creamy gel, color from white to yellowish.

Compound

100 g of the drug contains:

Active substance: 1.16 g of diclofenac diethylamine, which corresponds to 1 g of diclofenac sodium.

Excipients: carbomers (carbopol 974 R) 1.20 g, macrogol cetostearate (cetomacrogol 1000) 2.00 g, cocoyl caprylocaprate (cetiol LC) 2.50 g, diethylamine 0.90 g, isopropanol 20.00 g, liquid paraffin 2.50 g, aromatic cream 45 (contains benzyl benzoate) 0.10 g, propylene glycol 5.00 g, water 64.64 g.

Pharmacodynamics

The active component diclofenac is a non-steroidal anti-inflammatory drug with pronounced analgesic and anti-inflammatory properties. By indiscriminately inhibiting cyclooxygenase types 1 and 2, it disrupts the metabolism of arachidonic acid.

Voltaren® Emulgel® is used to eliminate pain and reduce swelling associated with the inflammatory process.

Thanks to its hydroalcoholic base, Voltaren® Emulgel® has a calming and cooling effect.

Pharmacokinetics

With the recommended method of applying the drug, no more than 6% of diclofenac is absorbed. When applied to the area of ​​the affected joint, the concentration in the synovial fluid is higher than in the plasma. Diclofenac is preferentially distributed and retained deep in tissues prone to inflammation, such as joints, where its concentration is 20 times higher than in plasma.

Side effects

Classification of the frequency of occurrence of adverse reactions: very often (≥1/10); often (≥1/100,<1/10); нечасто (≥1/1000, <1/100); редко (≥1/10000, <1/1000); очень редко (<1/10000), включая отдельные сообщения.

Very rare: pustular rash.

Immune system disorders:

Very rare: hypersensitivity reactions (including urticaria), angioedema.

Disorders of the respiratory system, chest and mediastinal organs:

Very rare: asthma.

Disorders of the skin and subcutaneous tissues:

Common: dermatitis (including contact dermatitis), rash, erythema, eczema, itching.

Rarely: bullous dermatitis.

Very rare: photosensitivity reactions.

If any of the side effects indicated in the instructions get worse, or you notice any other side effects not listed in the instructions, tell your doctor.

Selling Features

Available without a prescription

Special conditions

Voltaren® Emulgel® should be applied only to intact skin, avoiding contact with open wounds.

After application, do not apply an occlusive dressing.

The drug should not come into contact with the eyes and mucous membranes.

The drug contains propylene glycol and benzyl benzoate, which in some cases may cause mild local skin irritation. Treatment should be discontinued if a skin rash develops after application of the drug.

Effect of the drug on the ability to drive vehicles and machinery:

Does not affect.

Indications

Back pain due to inflammatory and degenerative diseases of the spine (sciatica, osteoarthritis, lumbago, sciatica);

Pain in the joints (fingers, knees, etc.) due to osteoarthritis;

Muscle pain (due to sprains, strains, bruises, injuries);

Inflammation and swelling of soft tissues and joints due to injuries and rheumatic diseases (tenosynovitis, bursitis, lesions of periarticular tissues).

Contraindications

Hypersensitivity to diclofenac or other components of the drug; tendency to develop attacks of bronchial asthma, skin rashes or acute rhinitis when using acetylsalicylic acid or other NSAIDs; pregnancy (III trimester), breastfeeding; children's age (up to 12 years); violation of the integrity of the skin at the intended site of application.

Carefully:

Hepatic porphyria (exacerbation), erosive and ulcerative lesions of the gastrointestinal tract, severe dysfunction of the liver and kidneys, chronic heart failure, bronchial asthma, old age, pregnancy (I and II trimester).

Pregnancy and lactation:

Due to the lack of data on the use of Voltaren® Emulgel® in pregnant women, the use of the drug during the first and second trimester of pregnancy is recommended only as prescribed by a doctor, weighing the benefits for the mother and the risk for the fetus.

The drug is contraindicated in the third trimester of pregnancy due to the possibility of decreased uterine tone, impaired fetal renal function with subsequent development of oligohydramnios and/or premature closure of the fetal ductus arteriosus.

Due to the lack of data on the penetration of Voltaren® Emulgel® into breast milk, the drug is not recommended for use during breastfeeding. If it is still necessary to use the drug, it should not be applied to the mammary glands or large surface areas of the skin and should not be used for a long time.

There are no data on the use of Voltaren® Emulgel® and its effect on fertility in humans.

Drug interactions

Voltaren® Emulgel® may enhance the effect of drugs that cause photosensitivity. Clinically significant interactions with other drugs have not been described.

Prices for Voltaren Emulgel in other cities

Buy Voltaren Emulgel,Voltaren Emulgel in St. Petersburg,Voltaren Emulgel in Novosibirsk,Voltaren Emulgel in Yekaterinburg,Voltaren Emulgel in Nizhny Novgorod,Voltaren Emulgel in Kazan,Voltaren Emulgel in Chelyabinsk,Voltaren Emulgel in Omsk,Voltaren Emulgel in Samara,Voltaren Emulgel in Rostov-on-Don,Voltaren Emulgel in Ufa,Voltaren Emulgel in Krasnoyarsk,Voltaren Emulgel in Perm,Voltaren Emulgel in Volgograd,Voltaren Emulgel in Voronezh,Voltaren Emulgel in Krasnodar,Voltaren Emulgel in Saratov,Voltaren Emulgel in Tyumen

Mode of application

Dosage

Externally.

For adults and children over 12 years of age, the drug is applied to the skin 3-4 times a day and lightly rubbed. The required amount of the drug depends on the size of the painful area. A single dose of the drug is 2-4 g (which is comparable in volume to the size of a cherry or walnut, respectively).

After applying the drug, hands must be washed.

The duration of treatment depends on the indications and the observed effect (to enhance the effect, the gel can be used together with other dosage forms of Voltaren®). Consult a doctor after 2 weeks if there is no therapeutic effect.

Laminated tubes: To remove the protective membrane, use the screw cap as a key (the ridged recess on the outside of the cap). Align the indentation on the outside of the cap with the shaped protective membrane of the tube and turn. The membrane should separate from the tube. Laminated tubes can have either a regular cap (round shape) or an innovative cap (triangular shape), which is especially convenient for use when the mobility of the hand joints is limited due to osteoarthritis or other joint diseases or injuries.

Aluminum tubes: Before first use, the protective membrane of the tube must be pierced using the special protrusion on the outside of the polypropylene screw cap.

Overdose

The extremely low systemic absorption of the active components of the drug when used externally makes overdose almost impossible. However, with accidental use of 100 g of gel, equivalent to 1000 mg of diclofenac, undesirable reactions similar to adverse reactions may occur.

First aid consists of gastric lavage and taking activated charcoal. If necessary, inpatient treatment.

Voltaren gel 1% contains 11.6 mg as an active ingredient diethylamine diclofenac (10 mg diclofenac sodium ) per 1 gram.

Additionally: polyethylene glycol cetostearyl ether, cocoyl caprylocaprate, propylene glycol, isopropyl alcohol, diethylamine, mineral oil, flavor 45 (including benzyl benzoate), purified water.

Voltaren Forte gel 2% contains 23.2 mg as an active ingredient diethylamine diclofenac (20 mg diclofenac sodium ) per 1 gram.

Additionally: carbomer, polyethylene glycol cetostearyl ether, cocoyl caprylocaprate, propylene glycol, isopropyl alcohol, diethylamine, mineral oil, oleyl alcohol, butylated hydroxytoluene (E 321), eucalyptus flavor, purified water.

Release form

External preparations Voltaren and Voltaren Forte are produced in the form of a gel (emulgel) of 20, 50 or 100 grams in aluminum or laminated tubes (Voltaren ointment is not available).

pharmachologic effect

Analgesic And anti-inflammatory of a local nature.

Pharmacodynamics and pharmacokinetics

Voltaren Emulgel in its regular and “Forte” form includes an active ingredient from the group NSAIDs -, which is a medicinal drug with a characteristically pronounced analgesic , antipyretic And anti-inflammatory efficiency. Action diclofenac manifests itself due to its indiscriminate inhibition of COX-1 and COX-2, which leads to disruption of the transformation arachidonic acid .

Gel Voltaren Emulgel is indicated for use in order to relieve the patient from inflammatory process And pain syndrome observed in muscle tissue, joints, ligaments and having rheumatic or traumatic character. The effects of the drug help reduce or completely relieve swelling and pain associated with the ongoing inflammatory process, as well as increase the mobility of joints that have been subjected to negative external or internal influences.

Quantity diclofenac , absorbed through the skin, corresponds to the surface area of ​​the skin to which the drug is applied, and depends on the degree of skin hydration and the total dosage of the medicinal product used. After 2 times applying Voltaren Forte (23.2 mg) to a skin surface area of ​​400 cm², the plasma concentration of its active ingredient corresponds to that after 4 times using regular Voltaren gel (11.6 mg). On the seventh day of use, the relative bioavailability of this medicinal drug is 4.5% (for an equivalent dose of diclofenac sodium). There was no change in suction when using a moisture-permeable dressing.

When Voltaren was applied to the affected joint area, the concentration of its active ingredient in the synovial fluid, membrane, and plasma was measured. Serum Cmax in this case was approximately 100 times lower than with oral administration of the same dosage diclofenac in tablets or capsules.

Connection diclofenac with plasma proteins is carried out by 99.7%, of which 99.4% of the drug binds to. Preferential distribution diclofenac observed deep in inflamed tissues, for example, in joints, where its content is 20 times higher than plasma concentration.

Metabolic transformations diclofenac occur partly by glucuronidation of its untransformed molecule, but mainly by hydroxylation (single and multiple), which leads to the release of several phenolic products, most of which are converted to the form of glucuronide conjugates. Biologically active are 2 phenolics diclofenac , but to a much lesser extent than their original active ingredient.

Systemic cumulative plasma clearance of the substance diclofenac equal to 263±56 ml/min. The final T1/2 takes 60-120 minutes. T1/2 of metabolic products (including two pharmacologically active metabolites) is also short and varies between 60-180 minutes. One of the completely inactive metabolites (3′-hydroxy-4′-methoxydiclofenac) is characterized by a longer T1/2, but this is not of fundamental importance. The main part of the active ingredient and its metabolic products are excreted by the kidneys.

Indications for use

Doctors recommend resorting to treatment with external preparations Voltaren for:

• back pain felt due to degenerative and inflammatory pathologies of the spine ( sciatica , );
• joint pain (joints of the knees, fingers, etc.), observed with osteoarthritis , etc.;
• swelling And inflammatory process , occurring in joints and soft tissues due to injury or due to rheumatic diseases ( wrist syndrome , tenosynovitis , inflammation of periarticular tissues, etc.);
• muscle pain noted due to overvoltage, sprains , injury, bruises ).

Contraindications

External use of Voltaren gel is contraindicated for:

• skin damage in the place necessary for applying the drug;
• III trimester;
• the patient's tendency to develop attacks of asthma (), acute or rashes on the skin observed when using medicinal products from the group NSAIDs ;
• under the age of 12;
• personal hypersensitivity patient to the emulgel ingredients ( diclofenac or additional components).

The gel should be used with caution when:

• exacerbation hepatic porphyria ;
• I and II trimester of pregnancy;
• erosive-ulcerative painful conditions of the gastrointestinal tract;
• bronchial asthma ;
• serious / ;
• heart failure ;
• bleeding disorders (including frequent and prolonged hemophilia );
• in old age.

Side effects

Negative side effects when using Voltaren emulgel externally are mainly manifested by passing and moderately expressed local skin reactions observed in the area where the drug is applied. Occasionally (with personal hypersensitivity ) possible formation phenomena .

The most common side effects are: and various, including contact dermatitis , characterized by swelling at the site of application of the gel, the formation rash , vesicles, papules and peeling .

Also, in some rare cases, doctors observed: pustular eruptions ,generalized rash , bronchospastic reactions, bullous dermatitis , allergic phenomena (,), asthma attacks, reactions photosensitivity .

Instructions for use of Voltaren Emulgel gel

External preparations Voltaren are produced by the manufacturer, both in aluminum and laminated tubes.

Before using the drug from an aluminum tube for the first time, the patient must pierce its protective membrane using a special protrusion located at the top of the screw cap.

To remove a similar protective membrane from a laminated tube, the patient should use its screw cap as a kind of key. To do this, it is necessary to combine the recesses present at the top of the lid with the protective membrane and turn the lid itself, which will lead to the separation of the membrane from the tube. Also, for the convenience of manipulation by patients with limited joint mobility of the hands (injuries, osteoarthritis, other joint pathologies), laminated tubes, in addition to the standard round cap, can be equipped with an innovative triangular cap, which is also used in other similar dosage forms (ointment, cream).

Instructions for use of Voltaren Emulgel ointment imply exclusively external use of this medicinal product.

Patients who have reached the age of 12 years are recommended to apply the emulgel to the skin over the problem area 3-4 times every 24 hours (for the “Forte” drug, 2 times in the morning and in the evening), rubbing lightly. The amount of gel used depends on the size of the affected area. A single dose of the remedy varies between 2 (the size of a cherry) or 4 (the size of a walnut) grams. This amount of the drug will be enough to apply to problem areas of 400 cm2 and, accordingly, 800 cm2.

If the patient's hands are not the treated area, they must be thoroughly washed after applying the emulgel.

The duration of such local therapy depends on the disease observed and the patient's response to treatment (efficacy). For rheumatic pathologies and post-traumatic inflammation, doctors do not recommend using external forms of Voltaren for more than 14 days in a row. If there is no effect or the condition worsens after 7 days of treatment, the patient should seek clarification from his doctor.

Overdose

Due to the insignificant systemic absorption observed during external use of the emulgel, the possibility of an overdose is extremely doubtful.

In the case of oral administration of this external medicinal product, the possibility of the occurrence of systemic negative phenomena is assumed, the relief of which can be reduced to: cleaning the gastrointestinal tract , reception sorbents and further symptomatic treatment.

Interaction

When used in parallel with drugs that have side effects such as photosensitivity , external means Voltaren can cause an increase in this negative effect.

Terms of sale

Voltaren gel is sold without a prescription.

Storage conditions

In original factory packaging (aluminum or laminated tubes), at a maximum of 30°C.

Best before date

Emulgel Voltaren in any external dosage form retains its properties for 3 years.

special instructions

External preparations Voltaren can only be applied to skin with an intact structure, avoiding contact of the emulgel on open wound surfaces.

It is necessary to exclude the possibility of the medication getting into the mouth, nose, eyes and other mucous membranes of the body.